The long-non-coding RNA NEAT1 is a novel target for Alzheimer’s disease progression via miR-124/BACE1 axis

References

• Bondi MW, Edmonds EC, Salmon DP. Alzheimer’s disease: past, present, and future. J Int Neuropsych Soc. 2017;23:818–831.
   PubMed Web of Science ®Google Scholar
• Hu Y, Xin J, Hu Y, et al. Analyzing the genes related to Alzheimer’s disease via a network and pathway-based approach. Alzheimer’s Res Ther. 2017;9.
   Web of Science ®Google Scholar
• Kommaddi RP, Das D, Karunakaran S, et al. Aβ mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer’s disease. J Neurosci. 2018;38:1085–1099.
   PubMed Web of Science ®Google Scholar
• Francelle L, Galvan L, Gaillard M, et al. The striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo. Neurobiol Aging. 2015;36:1601–1607.
   PubMed Web of Science ®Google Scholar
• Sunwoo J, Lee S, Im W, et al. Altered expression of the long noncoding RNA NEAT1 in Huntington’s disease. Mol Neurobiol. 2017;54:1577–1586.
   PubMed Web of Science ®Google Scholar
• Faghihi MA, Modarresi F, Khalil AM, et al. Expression of a noncoding RNA is elevated in Alzheimer’s disease and drives rapid feed-forward regulation of beta-secretase. Nat Med. 2008;14:723–730.
   PubMed Web of Science ®Google Scholar
• Jiang X, Zhou Y, Sun A, et al. NEAT1 contributes to breast cancer progression through modulating miR-448 and ZEB1. J Cell Physiol. 2018.
   Web of Science ®Google Scholar
• Li S, Yang J, Xia Y, et al. Long noncoding RNA NEAT1 promotes proliferation and invasion via targeting miR-181a-5p in non-small cell lung cancer. Oncol Res Featuring Preclinical Clin Cancer Ther. 2018;26:289–296.
   Google Scholar
• Cheng N, Guo Y. Long noncoding RNA NEAT1 promotes nasopharyngeal carcinoma progression through regulation of miR-124/NF-κB pathway. 2017;10:5843–5853.
   Google Scholar
• Salta E, De Strooper B. microRNA-132: a key noncoding RNA operating in the cellular phase of Alzheimer’s disease. Faseb J. 2017;31:424–433.
   PubMed Web of Science ®Google Scholar
• Ma X, Liu L, Meng J. MicroRNA-125b promotes neurons cell apoptosis and Tau phosphorylation in Alzheimer’s disease. Neurosci Lett. 2017;661:57–62.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Unmehopa U, Bossers K, et al. MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer’s disease. Brain. 2016;139:908–921.
   PubMed Web of Science ®Google Scholar
• Femminella GD, Ferrara N, Rengo G. The emerging role of microRNAs in Alzheimer’s disease. Front Physiol. 2015;6:40.
   PubMed Web of Science ®Google Scholar
• Basavaraju M, de Lencastre A. Alzheimer’s disease: presence and role of microRNAs. Biomol Concepts. 2016;7:241–252.
   PubMedGoogle Scholar
• Zhang X, Huang X, Fang C, et al. miR-124 regulates the expression of BACE1 in the hippocampus under chronic cerebral hypoperfusion. Mol Neurobiol. 2017;54:2498–2506.
   PubMed Web of Science ®Google Scholar
• Du X, Huo X, Yang Y, et al. miR-124 downregulates BACE 1 and alters autophagy in APP/PS1 transgenic mice. Toxicol Lett. 2017;280:195–205.
   PubMed Web of Science ®Google Scholar
• Fang M, Wang J, Zhang X, et al. The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer’s disease. Toxicol Lett. 2012;209:94–105.
   PubMed Web of Science ®Google Scholar
• Nakhate KT, Bharne AP, Verma VS, et al. Plumbagin ameliorates memory dysfunction in streptozotocin induced Alzheimer’s disease via activation of Nrf2/ARE pathway and inhibition of beta-secretase. Biomed Pharmacother. 2018;101:379–390.
   PubMed Web of Science ®Google Scholar
• Hebert SS, Horre K, Nicolai L, et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A. 2008;105:6415–6420.
   PubMed Web of Science ®Google Scholar
• Masters CL, Selkoe DJ. Biochemistry of amyloid beta-protein and amyloid deposits in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2:a6262.
   PubMed Web of Science ®Google Scholar
• Lesne SE, Sherman MA, Grant M, et al. Brain amyloid-beta oligomers in ageing and Alzheimer’s disease. Brain. 2013;136:1383–1398.
   PubMed Web of Science ®Google Scholar
• Barao S, Moechars D, Lichtenthaler SF, et al. BACE1 physiological functions may limit its use as therapeutic target for Alzheimer’s disease. Trends Neurosci. 2016;39:158–169.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Pogue A, Lukiw W. MicroRNA (miRNA) signaling in the human CNS in sporadic Alzheimer’s disease (AD)-novel and unique pathological features. Int J Mol Sci. 2015;16:30105–30116.
   PubMed Web of Science ®Google Scholar
• Kraus TFJ, Haider M, Spanner J, et al. Altered long noncoding RNA expression precedes the course of Parkinson’s disease—a preliminary report. Mol Neurobiol. 2017;54:2869–2877.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zou Q, Song M, et al. NEAT1 promotes cell proliferation and invasion in hepatocellular carcinoma by negative regulating miR-613 expression. Biomed Pharmacother. 2017;94:612–618.
   PubMed Web of Science ®Google Scholar
• Tan H, Wang C, Liu G, et al. Long noncoding RNA NEAT1-modualted miR-506 regulates gastric cancer development through targeting STAT3. J Cell Biochem. 2018.
   Web of Science ®Google Scholar
• Liu Y, Lu Z. Long non-coding RNA NEAT1 mediates the toxic of Parkinson’s disease induced by MPTP/MPP+ via regulation of gene expression. Clin Exp Pharmacol P. 2018.
   Web of Science ®Google Scholar
• Spreafico M, Grillo B, Rusconi F, et al. Multiple layers of CDK5R1 regulation in Alzheimer’s disease implicate long non-coding RNAs. Int J Mol Sci. 2018;19:2022.
   Web of Science ®Google Scholar
• An F, Gong G, Wang Y, et al. MiR-124 acts as a target for Alzheimer’s disease by regulating BACE1. Oncotarget. 2017;8:114065–114071.
   PubMedGoogle Scholar
• Gong X, Wang H, Ye Y, et al. miR-124 regulates cell apoptosis and autophagy in dopaminergic neurons and protects them by regulating AMPK/mTOR pathway in Parkinson’s disease. Am J Transl Res. 2016;8:2127–2137.
   PubMed Web of Science ®Google Scholar
• Yan R. Physiological functions of the beta-site amyloid precursor protein cleaving enzyme 1 and 2. Front Mol Neurosci. 2017;10:97.
   PubMed Web of Science ®Google Scholar
• Barao S, Gartner A, Leyva-Diaz E, et al. Antagonistic effects of bace1 and aph1b-gamma-secretase control axonal guidance by regulating growth cone collapse. Cell Rep. 2015;12:1367–1376.
   PubMed Web of Science ®Google Scholar
• Baek SH, Park SJ, Jeong JI, et al. Inhibition of drp1 ameliorates synaptic depression, abeta deposition, and cognitive impairment in an Alzheimer’s Disease Model. J Neurosci. 2017;37:5099–5110.
   PubMed Web of Science ®Google Scholar